Sanofi, GSK launch vaccine trial
Sanofi, GSK launch vaccine trial

Drugmakers Sanofi and GlaxoSmithKline say they have launched clinical trials of a protein-based vaccine against COVID-19.

Julian Satterthwaite reports.